“…1,2 Recently, the low UA level in the serum and/or cerebrospinal fluid has been proved to be a key biomarker of Parkinson disease. 3 In the past years, some analytical methods have been developed for UA detection, including highperformance liquid chromatography (HPLC), 4 chemiluminescence, 5 electrochemistry, [6][7][8] enzymatic assay, 9,10 fluorescence, 11,12 surface plasmon resonance, 3 and photoelectrochemistry. 11,12 Despite many advances in UA detection, many of these methods still do not meet the growing demand for more sensitive and selective detection of UA.…”